AbCellera Biologics Inc. (ABCL) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	8-K	S-1
Assets
Current assets:
Cash and cash equivalents	386.5	476.1	594.1
Marketable securities	500.0	246.8
Total cash, cash equivalents, and marketable securities	886.5	723.0	594.1
Accounts and accrued receivable	38.6	160.6	213.2
Restricted cash	81.2	25.0
Other current assets	75.4	21.2	6.0
Total current assets	1,025.5	929.8	813.3

Long-term assets:
Property and equipment, net	217.3	111.6	17.9
Intangible assets, net	131.5	148.4	115.2
Goodwill	47.8	47.8	31.5
Investments in and loans to equity accounted investees	72.5	50.3	19.2
Other long-term assets	46.3	30.6	8.4

Total long-term assets
Total assets	1,540.9	1,318.6	1,005.5

Liabilities and shareholders' equity
Current liabilities:
Accounts payable and other liabilities	33.2	32.0	20.2
Contingent consideration payable	44.2	22.9	13.4
Accrued royalties payable	19.3	22.5	27.1
Deferred revenue	21.6	7.5	6.6
Total current liabilities	118.3	120.7	103.5

Long-term liabilities:
Operating lease liability	76.7	36.4	3.7
Deferred revenue	19.5	27.4
Contingent consideration payable	16.1	35.9	9.1
Deferred tax liability	33.2	37.4	26.2
Other long-term liabilities	3.1	1.7	6.6
Total long-term liabilities	189.3	172.2	71.5
Total liabilities	307.6	292.8	175.0

Commitments and contingencies
Shareholders' equity:
Common shares: no par value	734.4	722.4	710.4
Additional paid-in capital	74.1	35.4	5.9
Accumulated other comprehensive (loss)	-1.4	0.3
Accumulated earnings	426.2	267.7	114.2
Total shareholders' equity	1,233.3	1,025.7	830.5
Total liabilities and shareholders' equity	1,540.9	1,318.6	1,005.5